Patents by Inventor Nitin Laddha

Nitin Laddha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTRANASAL PHARMACEUTICAL COMPOSITIONS OF CYCLOBENZAPRINE
    Publication number: 20220339124
    Abstract: The present invention relates to intranasal pharmaceutical compositions comprising cyclobenzaprine or salts thereof for the treatment or management of muscle spasms in musculoskeletal diseases and/or painful physical symptoms in neurological diseases. In particular, the invention relates to intranasal pharmaceutical compositions comprising cyclobenzaprine or salts thereof and one or more pharmaceutically acceptable excipients.
    Type: Application
    Filed: September 30, 2020
    Publication date: October 27, 2022
    Inventors: Kannan Essakimuthu MUTHAIYYAN, Ritu Nitin LADDHA, Harish PAWAR, Shailesh Arvindbhai PATEL, Jay Shantilal KOTHARI
  • Pharmaceutical compositions of curcumin
    Patent number: 9474727
    Abstract: The present invention relates to stable liquid pharmaceutical compositions of curcumin or its pharmaceutically acceptable salts or its derivatives with higher curcumin concentration and improved bioavailability without the use of buffer and/or molecular aggregation inhibitor(s). In accordance with present invention the curcumin is in the solubilized form to make a stable liquid pharmaceutical composition.
    Type: Grant
    Filed: September 12, 2011
    Date of Patent: October 25, 2016
    Assignee: Cadila Pharmaceuticals Limited
    Inventors: Bakulesh Mafatlal Khamar, Ashish Premkumar Gogia, Chirag Chandrakant Goda, Dinesh Balkunje Shenoy, Rajneesh Ramesh Shrivastava, Vandana Bharat Patravale, Indravadan Ambalal Modi, Ritu Nitin Laddha, Imran Ahmad Khan, Rajiv Indravadan Modi
  • Pharmaceutical composition of taxoids
    Patent number: 9345683
    Abstract: The present invention relates to a stable oral pharmaceutical composition with improved solubility and bioavailability; comprising a taxoid, a solubilizer, a stabilizing agent, a surfactant(s), a solvent(s), and an oil wherein the concentration of taxoid is in the range of 0.1 to 10%.
    Type: Grant
    Filed: November 5, 2011
    Date of Patent: May 24, 2016
    Assignee: Cadila Pharmaceuticals Limited
    Inventors: Bakulesh Mafatlal Khamar, Ashish Premkumar Gogia, Ritu Nitin Laddha, Imran Ahmed Khan, Vandana Bharat Patravale, Indravadan Ambalal Modi
  • PHARMACEUTICAL COMPOSITION OF TAXOIDS
    Publication number: 20130310447
    Abstract: The present invention relates to a stable oral pharmaceutical composition with improved solubility and bioavailability; comprising a taxoid, a solubilizer, a stabilizing agent, a surfactant(s), a solvent(s), and an oil wherein the concentration of taxoid is in the range of 0.1 to 10%.
    Type: Application
    Filed: November 5, 2011
    Publication date: November 21, 2013
    Applicant: CADILA PHARMACEUTICALS LIMITED
    Inventors: Bakulesh Mafatlal Khamar, Ashish Premkumar Gogia, Ritu Nitin Laddha, Imran Ahmed Khan, Vandana Bharat Patravale, Indravadan Ambalal Modi
  • Low dose corticosteroid composition
    Publication number: 20060193783
    Abstract: The present invention relates to a low dose composition of budesonide suitable for administration of budesonide to mucosal membranes for the management of nasal symptoms associated with seasonal allergic rhinitis, perennial allergic rhinitis, perennial non-allergic rhinitis, nasal polyps, as well as prevention of post surgical polyps, chronic sinusitis and recurrent sinusitis comprising budesonide at a therapeutically effective dose of less than 16 mcg and a pharmaceutically acceptable liquid carrier.
    Type: Application
    Filed: February 16, 2004
    Publication date: August 31, 2006
    Inventors: Balaram Bhowmick, Nitin Laddha, Jaysingh Khopade
  • Stable aqueous composition of a peptide
    Publication number: 20030216302
    Abstract: The present invention relates to a stable aqueous composition comprising desmopressin or its other pharmaceutically acceptable salts in a pharmaceutically acceptable carrier, wherein the carrier comprises a buffering agent, a parahydroxybenzoate preservative, and a cosolvent.
    Type: Application
    Filed: May 14, 2003
    Publication date: November 20, 2003
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Subhas Balaram Bhowmick, Ritu Nitin Laddha